The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prostate cancer intensive, non-cross reactive therapy (PRINT) for CRPC: Interim analysis of efficacy endpoints.
 
Bobby Chi-Hung Liaw
Consulting or Advisory Role - Amgen; Baxter; Daiichi Sankyo; Eisai; EMD Serono; Exelixis; Genomic Health; Myovant Sciences
Research Funding - Bayer; Sanofi
 
Xiaobo Zhong
No Relationships to Disclose
 
Che-Kai Tsao
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Eisai; Pfizer
 
Richard Lorne Bakst
No Relationships to Disclose
 
Robert Stewart
No Relationships to Disclose
 
Richard Stock
No Relationships to Disclose
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Aileron Therapeutics; Astellas Pharma; AstraZeneca; Basilea; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; GlaxoSmithKline; Incyte; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen; Urogen pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
William K. Oh
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bayer; Conjupro Biotherapeutics; Foundry; HUYA Bioscience International; Janssen; Sanofi; Sema4; TeneoBio